» Articles » PMID: 32547096

Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT Via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Jun 18
PMID 32547096
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To explore the effects of FAM83D on the proliferation, invasion and radiosensitivity of human esophageal cancer cells and to elucidate the mechanism involved in the regulation of the growth and metastasis of esophageal cancer cells.

Methods And Materials: This study included sixty-nine patients with esophageal cancer. The expression levels of FAM83D in the esophageal cancer tissues and paracarcinoma tissues of the sixty-nine patients were measured. We also examined FAM83D expression in five cell lines. We analyzed the effects of FAM83D on the proliferation, invasion and radiosensitivity of human esophageal cancer cells via MTS, Transwell, and colony formation assays. The effect of FAM83D knockdown on cell apoptosis was assayed by flow cytometry. In addition, we also examined changes in the expression of metastasis-related molecules at the protein and mRNA levels by qRT-PCR and Western blotting after silencing FAM83D expression, and we detected the expression of PI3K/Akt signaling-related proteins by Western blotting.

Results: The results demonstrated that the expression of FAM83D was obviously higher in esophageal cancer tissues and cell lines than that in human adjacent normal tissues and normal esophageal epithelial cell lines. FAM83D overexpression was positively associated with tumor size, tumor-node-metastasis (TNM) stage, T classification, N classification, distant metastasis and relapse and was negatively associated with patient survival rates. FAM83D shRNA transfection suppressed its expression. Compared to that in the control group, the proliferation of tumor cells in the FAM83D shRNA group was hindered after exposure to radiation in vitro and in vivo; in addition, FAM83D knockdown inhibited cell invasion, induced apoptosis and regulated apoptosis-related protein expression. Moreover, the radiosensitivity of esophageal cancer cells was increased after depletion of FAM83D. In addition, FAM83D silencing was associated with the reversion of EMT, as reflected by an increase in the epithelial marker E-cadherin and a decrease in the mesenchymal markers N-cadherin and vimentin. Further study showed that FAM83D depletion suppressed the signaling pathway involving p-Akt, p-GSK-3β and Snail.

Conclusion: The results reveal that FAM83D may be a potential therapeutic target for esophageal squamous cell carcinoma (ESCC) and that lower expression of FAM83D in coordination with irradiation promotes the radiosensitization of ESCC by inducing EMT through the Akt/GSK-3β/Snail signaling pathway.

Citing Articles

Oxymatrine inhibits the development of radioresistance in NSCLC cells by reversing EMT through the DcR3/AKT/GSK-3β pathway.

Tang J, Cao Y, Zhang H, Wang R Arch Med Sci. 2024; 20(5):1631-1654.

PMID: 39649262 PMC: 11623166. DOI: 10.5114/aoms/158533.


The FBXW7-binding sites on FAM83D are potential targets for cancer therapy.

Jiang X, Wang Y, Guo L, Wang Y, Miao T, Ma L Breast Cancer Res. 2024; 26(1):37.

PMID: 38454442 PMC: 10918900. DOI: 10.1186/s13058-024-01795-9.


Integrating single-cell RNA sequencing and prognostic model revealed the carcinogenicity and clinical significance of FAM83D in ovarian cancer.

Li J, Li Z, Gao Y, Zhao H, Guo J, Liu Z Front Oncol. 2022; 12:1055648.

PMID: 36568230 PMC: 9773999. DOI: 10.3389/fonc.2022.1055648.


Inositol monophosphatase 1 (IMPA1) promotes triple-negative breast cancer progression through regulating mTOR pathway and EMT process.

Yang S, Xie Y, Zhang T, Deng L, Liao L, Hu S Cancer Med. 2022; 12(2):1602-1615.

PMID: 35796646 PMC: 9883559. DOI: 10.1002/cam4.4970.


HuR Affects the Radiosensitivity of Esophageal Cancer by Regulating the EMT-Related Protein Snail.

Hu Y, Li Q, Yi K, Yang C, Lei Q, Wang G Front Oncol. 2022; 12:883444.

PMID: 35664798 PMC: 9160430. DOI: 10.3389/fonc.2022.883444.


References
1.
Wang D, Han S, Peng R, Wang X, Yang X, Yang R . FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma. Biochem Biophys Res Commun. 2015; 458(2):313-20. DOI: 10.1016/j.bbrc.2015.01.108. View

2.
Zhu P, Zhang J, Zhu J, Shi J, Zhu Q, Gao Y . MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2. Cell Physiol Biochem. 2015; 37(4):1572-80. DOI: 10.1159/000438524. View

3.
Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J . FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Cell Oncol (Dordr). 2020; 43(3):395-407. DOI: 10.1007/s13402-020-00494-9. View

4.
Liao W, Liu W, Liu X, Yuan Q, Ou Y, Qi Y . Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Oncotarget. 2015; 6(27):24132-47. PMC: 4695175. DOI: 10.18632/oncotarget.4432. View

5.
Shi R, Sun J, Sun Q, Zhang Q, Xia W, Dong G . Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle. Am J Cancer Res. 2016; 6(11):2587-2598. PMC: 5126275. View